A biophysical perspective on the unexplored mechanisms driving Parkinson’s disease by amphetamine-like stimulants
Main Authors: | Carla Ferreira, Joana Couceiro, Sandra Tenreiro, Alexandre Quintas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=11;spage=2213;epage=2214;aulast=Ferreira |
Similar Items
-
Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
by: Carla Ferreira, et al.
Published: (2020-06-01) -
Therapeutic deep brain stimulation worsening dysprosody in Parkinson’s disease – an unexplored entity
by: Shoaib M, et al.
Published: (2018-03-01) -
Increased antidepressant-like effect of desipramine combined with central stimulants (caffeine and amphetamine) in mice
by: Robles-Molina Evelyn, et al.
Published: (2012-06-01) -
Mechanisms of enhancement and blockade by amphetamine in directly-stimulated rat skeletal muscle /
by: Meldrum, Michael Jay
Published: (1980) -
Neuropharmacology of new psychoactive substances (NPS): focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants
by: Cristina eMiliano, et al.
Published: (2016-04-01)